ArticleCell reports. Medicine2026

Repurposed ethoxzolamide reprograms antitumor immunity through β-TrCP-dependent PD-L1 ubiquitination.

Xuwen Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.